Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 6 |
GO:0005777 | peroxisome | 6 | 2 |
GO:0005829 | cytosol | 2 | 2 |
GO:0020015 | glycosome | 7 | 2 |
GO:0020022 | acidocalcisome | 5 | 2 |
GO:0031974 | membrane-enclosed lumen | 2 | 2 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0042579 | microbody | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 2 |
GO:0070013 | intracellular organelle lumen | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 6 |
GO:0006144 | purine nucleobase metabolic process | 5 | 2 |
GO:0006163 | purine nucleotide metabolic process | 5 | 6 |
GO:0006164 | purine nucleotide biosynthetic process | 6 | 6 |
GO:0006166 | purine ribonucleoside salvage | 5 | 6 |
GO:0006177 | GMP biosynthetic process | 8 | 2 |
GO:0006178 | guanine salvage | 6 | 2 |
GO:0006188 | IMP biosynthetic process | 8 | 6 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 6 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 6 |
GO:0006793 | phosphorus metabolic process | 3 | 6 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 6 |
GO:0006807 | nitrogen compound metabolic process | 2 | 6 |
GO:0008152 | metabolic process | 1 | 6 |
GO:0009058 | biosynthetic process | 2 | 6 |
GO:0009112 | nucleobase metabolic process | 4 | 2 |
GO:0009113 | purine nucleobase biosynthetic process | 6 | 2 |
GO:0009116 | nucleoside metabolic process | 4 | 6 |
GO:0009117 | nucleotide metabolic process | 5 | 6 |
GO:0009119 | ribonucleoside metabolic process | 5 | 6 |
GO:0009123 | nucleoside monophosphate metabolic process | 5 | 6 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 6 | 6 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 6 | 6 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 7 | 6 |
GO:0009150 | purine ribonucleotide metabolic process | 6 | 6 |
GO:0009152 | purine ribonucleotide biosynthetic process | 7 | 6 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 7 | 6 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 6 | 6 |
GO:0009163 | nucleoside biosynthetic process | 5 | 6 |
GO:0009165 | nucleotide biosynthetic process | 6 | 6 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 7 | 6 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 8 | 6 |
GO:0009259 | ribonucleotide metabolic process | 5 | 6 |
GO:0009260 | ribonucleotide biosynthetic process | 6 | 6 |
GO:0009987 | cellular process | 1 | 6 |
GO:0018130 | heterocycle biosynthetic process | 4 | 6 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 6 |
GO:0019637 | organophosphate metabolic process | 3 | 6 |
GO:0019693 | ribose phosphate metabolic process | 4 | 6 |
GO:0032261 | purine nucleotide salvage | 5 | 6 |
GO:0032263 | GMP salvage | 7 | 2 |
GO:0032264 | IMP salvage | 7 | 6 |
GO:0034404 | nucleobase-containing small molecule biosynthetic process | 4 | 6 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 6 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 6 |
GO:0042278 | purine nucleoside metabolic process | 5 | 6 |
GO:0042451 | purine nucleoside biosynthetic process | 6 | 6 |
GO:0042455 | ribonucleoside biosynthetic process | 6 | 6 |
GO:0043094 | cellular metabolic compound salvage | 3 | 6 |
GO:0043096 | purine nucleobase salvage | 5 | 2 |
GO:0043101 | purine-containing compound salvage | 4 | 6 |
GO:0043173 | nucleotide salvage | 4 | 6 |
GO:0043174 | nucleoside salvage | 4 | 6 |
GO:0044237 | cellular metabolic process | 2 | 6 |
GO:0044238 | primary metabolic process | 2 | 6 |
GO:0044249 | cellular biosynthetic process | 3 | 6 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 6 |
GO:0044281 | small molecule metabolic process | 2 | 6 |
GO:0044283 | small molecule biosynthetic process | 3 | 6 |
GO:0046037 | GMP metabolic process | 7 | 2 |
GO:0046040 | IMP metabolic process | 7 | 6 |
GO:0046098 | guanine metabolic process | 6 | 2 |
GO:0046099 | guanine biosynthetic process | 7 | 2 |
GO:0046100 | hypoxanthine metabolic process | 6 | 2 |
GO:0046112 | nucleobase biosynthetic process | 5 | 2 |
GO:0046128 | purine ribonucleoside metabolic process | 6 | 6 |
GO:0046129 | purine ribonucleoside biosynthetic process | 7 | 6 |
GO:0046390 | ribose phosphate biosynthetic process | 5 | 6 |
GO:0046483 | heterocycle metabolic process | 3 | 6 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 6 |
GO:0071704 | organic substance metabolic process | 2 | 6 |
GO:0072521 | purine-containing compound metabolic process | 4 | 6 |
GO:0072522 | purine-containing compound biosynthetic process | 5 | 6 |
GO:0090407 | organophosphate biosynthetic process | 4 | 6 |
GO:0106380 | purine ribonucleotide salvage | 6 | 6 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 6 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 6 |
GO:1901293 | nucleoside phosphate biosynthetic process | 5 | 6 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 6 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 6 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 6 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 6 |
GO:1901576 | organic substance biosynthetic process | 3 | 6 |
GO:1901657 | glycosyl compound metabolic process | 4 | 6 |
GO:1901659 | glycosyl compound biosynthetic process | 5 | 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 6 |
GO:0000287 | magnesium ion binding | 5 | 2 |
GO:0003824 | catalytic activity | 1 | 6 |
GO:0004422 | hypoxanthine phosphoribosyltransferase activity | 6 | 6 |
GO:0005488 | binding | 1 | 6 |
GO:0016740 | transferase activity | 2 | 6 |
GO:0016757 | glycosyltransferase activity | 3 | 6 |
GO:0016763 | pentosyltransferase activity | 4 | 6 |
GO:0036094 | small molecule binding | 2 | 6 |
GO:0043167 | ion binding | 2 | 6 |
GO:0043169 | cation binding | 3 | 6 |
GO:0046872 | metal ion binding | 4 | 6 |
GO:0052657 | guanine phosphoribosyltransferase activity | 6 | 6 |
GO:0097159 | organic cyclic compound binding | 2 | 6 |
GO:0106130 | purine phosphoribosyltransferase activity | 5 | 6 |
GO:1901265 | nucleoside phosphate binding | 3 | 6 |
GO:1901363 | heterocyclic compound binding | 2 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 111 | 115 | PF00656 | 0.548 |
CLV_C14_Caspase3-7 | 126 | 130 | PF00656 | 0.437 |
CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.445 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.484 |
CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.484 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.359 |
CLV_PCSK_SKI1_1 | 139 | 143 | PF00082 | 0.211 |
CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.324 |
CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.285 |
DOC_CYCLIN_RxL_1 | 104 | 114 | PF00134 | 0.543 |
DOC_MAPK_gen_1 | 161 | 167 | PF00069 | 0.561 |
DOC_PP1_RVXF_1 | 85 | 91 | PF00149 | 0.543 |
DOC_USP7_UBL2_3 | 206 | 210 | PF12436 | 0.609 |
DOC_USP7_UBL2_3 | 39 | 43 | PF12436 | 0.496 |
DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.654 |
LIG_Actin_WH2_2 | 134 | 152 | PF00022 | 0.543 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.663 |
LIG_BRCT_BRCA1_1 | 67 | 71 | PF00533 | 0.645 |
LIG_FHA_1 | 149 | 155 | PF00498 | 0.552 |
LIG_FHA_1 | 70 | 76 | PF00498 | 0.543 |
LIG_FHA_2 | 96 | 102 | PF00498 | 0.496 |
LIG_LIR_Apic_2 | 202 | 207 | PF02991 | 0.528 |
LIG_LIR_Nem_3 | 168 | 172 | PF02991 | 0.635 |
LIG_LIR_Nem_3 | 188 | 193 | PF02991 | 0.408 |
LIG_LIR_Nem_3 | 46 | 51 | PF02991 | 0.638 |
LIG_LYPXL_yS_3 | 169 | 172 | PF13949 | 0.543 |
LIG_PDZ_Class_1 | 206 | 211 | PF00595 | 0.618 |
LIG_PTB_Apo_2 | 54 | 61 | PF02174 | 0.512 |
LIG_PTB_Phospho_1 | 54 | 60 | PF10480 | 0.512 |
LIG_SH2_NCK_1 | 204 | 208 | PF00017 | 0.511 |
LIG_SH2_SRC | 186 | 189 | PF00017 | 0.434 |
LIG_SH2_STAP1 | 186 | 190 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 136 | 139 | PF00017 | 0.606 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.599 |
LIG_SH3_3 | 164 | 170 | PF00018 | 0.543 |
LIG_SUMO_SIM_anti_2 | 151 | 156 | PF11976 | 0.543 |
LIG_SUMO_SIM_par_1 | 108 | 115 | PF11976 | 0.579 |
LIG_SUMO_SIM_par_1 | 120 | 126 | PF11976 | 0.559 |
LIG_SUMO_SIM_par_1 | 150 | 156 | PF11976 | 0.543 |
LIG_TYR_ITIM | 167 | 172 | PF00017 | 0.543 |
LIG_UBA3_1 | 137 | 145 | PF00899 | 0.550 |
LIG_UBA3_1 | 61 | 66 | PF00899 | 0.614 |
LIG_WRC_WIRS_1 | 48 | 53 | PF05994 | 0.512 |
MOD_CK1_1 | 130 | 136 | PF00069 | 0.645 |
MOD_CK1_1 | 148 | 154 | PF00069 | 0.422 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.484 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.647 |
MOD_CK1_1 | 95 | 101 | PF00069 | 0.575 |
MOD_CK2_1 | 186 | 192 | PF00069 | 0.466 |
MOD_CK2_1 | 95 | 101 | PF00069 | 0.523 |
MOD_Cter_Amidation | 15 | 18 | PF01082 | 0.519 |
MOD_Cter_Amidation | 159 | 162 | PF01082 | 0.312 |
MOD_GlcNHglycan | 101 | 105 | PF01048 | 0.395 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.445 |
MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.312 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.464 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.681 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.610 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.533 |
MOD_GSK3_1 | 65 | 72 | PF00069 | 0.645 |
MOD_GSK3_1 | 91 | 98 | PF00069 | 0.559 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.620 |
MOD_NEK2_1 | 51 | 56 | PF00069 | 0.495 |
MOD_NEK2_1 | 65 | 70 | PF00069 | 0.645 |
MOD_PIKK_1 | 26 | 32 | PF00454 | 0.471 |
MOD_PKA_2 | 112 | 118 | PF00069 | 0.553 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.631 |
MOD_Plk_4 | 23 | 29 | PF00069 | 0.449 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.639 |
MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.651 |
MOD_SUMO_for_1 | 199 | 202 | PF00179 | 0.478 |
MOD_SUMO_for_1 | 86 | 89 | PF00179 | 0.512 |
MOD_SUMO_rev_2 | 202 | 211 | PF00179 | 0.527 |
TRG_ENDOCYTIC_2 | 169 | 172 | PF00928 | 0.645 |
TRG_ENDOCYTIC_2 | 190 | 193 | PF00928 | 0.581 |
TRG_ENDOCYTIC_2 | 48 | 51 | PF00928 | 0.645 |
TRG_Pf-PMV_PEXEL_1 | 107 | 111 | PF00026 | 0.343 |
TRG_Pf-PMV_PEXEL_1 | 191 | 195 | PF00026 | 0.443 |
TRG_Pf-PMV_PEXEL_1 | 77 | 81 | PF00026 | 0.445 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IHW3 | Leptomonas seymouri | 34% | 88% |
A0A0N1PCR6 | Leptomonas seymouri | 78% | 100% |
A0A0S4JHI0 | Bodo saltans | 55% | 99% |
A0A0S4JLD9 | Bodo saltans | 53% | 100% |
A0A1X0NZ20 | Trypanosomatidae | 60% | 100% |
A0A1X0NZ92 | Trypanosomatidae | 37% | 91% |
A0A422N3N7 | Trypanosoma rangeli | 36% | 92% |
A0A422N3S1 | Trypanosoma rangeli | 59% | 97% |
A4HBT6 | Leishmania braziliensis | 82% | 100% |
A4HBT7 | Leishmania braziliensis | 35% | 88% |
A4II60 | Xenopus tropicalis | 31% | 94% |
A5A6I1 | Pan troglodytes | 34% | 97% |
D0A1D6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 90% |
D0A1D7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
D0A1E6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9AGU6 | Leishmania infantum | 99% | 100% |
E9AGU7 | Leishmania infantum | 33% | 88% |
E9AV58 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
E9AV59 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 89% |
O33799 | Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) | 39% | 100% |
O66821 | Aquifex aeolicus (strain VF5) | 34% | 100% |
O69537 | Mycobacterium leprae (strain TN) | 41% | 100% |
P00492 | Homo sapiens | 33% | 97% |
P00493 | Mus musculus | 33% | 97% |
P00494 | Cricetulus griseus | 29% | 97% |
P07833 | Plasmodium falciparum (isolate K1 / Thailand) | 27% | 91% |
P09383 | Schistosoma mansoni | 28% | 74% |
P0A5T1 | Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) | 40% | 100% |
P0A9M2 | Escherichia coli (strain K12) | 38% | 100% |
P0A9M3 | Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC) | 38% | 100% |
P0A9M4 | Shigella flexneri | 38% | 100% |
P0DD40 | Streptococcus pyogenes serotype M3 (strain ATCC BAA-595 / MGAS315) | 39% | 100% |
P0DD41 | Streptococcus pyogenes serotype M3 (strain SSI-1) | 39% | 100% |
P18134 | Vibrio harveyi | 39% | 100% |
P20035 | Plasmodium falciparum (isolate FCR-3 / Gambia) | 27% | 91% |
P27605 | Rattus norvegicus | 33% | 97% |
P37171 | Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) | 40% | 100% |
P37472 | Bacillus subtilis (strain 168) | 41% | 100% |
P43152 | Leishmania donovani | 99% | 100% |
P45078 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 40% | 100% |
P47696 | Mycoplasma genitalium (strain ATCC 33530 / DSM 19775 / NCTC 10195 / G37) | 22% | 100% |
P47959 | Meriones unguiculatus | 29% | 97% |
P51900 | Tritrichomonas foetus | 34% | 100% |
P57291 | Buchnera aphidicola subsp. Acyrthosiphon pisum (strain APS) | 37% | 100% |
P65827 | Staphylococcus aureus (strain Mu50 / ATCC 700699) | 36% | 100% |
P65828 | Staphylococcus aureus (strain MW2) | 36% | 100% |
P75119 | Mycoplasma pneumoniae (strain ATCC 29342 / M129 / Subtype 1) | 26% | 100% |
P96794 | Mycobacterium avium | 42% | 100% |
P99085 | Staphylococcus aureus (strain N315) | 36% | 100% |
P9WHQ8 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 40% | 100% |
P9WHQ9 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 40% | 100% |
Q02522 | Lactococcus lactis subsp. lactis (strain IL1403) | 46% | 100% |
Q07010 | Trypanosoma brucei brucei | 43% | 100% |
Q26997 | Toxoplasma gondii | 29% | 92% |
Q27541 | Crithidia fasciculata | 81% | 100% |
Q3SZ18 | Bos taurus | 30% | 97% |
Q45FY6 | Sus scrofa | 33% | 97% |
Q4QCC2 | Leishmania major | 34% | 100% |
Q54NJ8 | Dictyostelium discoideum | 42% | 100% |
Q5HIG5 | Staphylococcus aureus (strain COL) | 36% | 100% |
Q5HRP4 | Staphylococcus epidermidis (strain ATCC 35984 / RP62A) | 36% | 100% |
Q5M216 | Streptococcus thermophilus (strain CNRZ 1066) | 38% | 100% |
Q5M6K8 | Streptococcus thermophilus (strain ATCC BAA-250 / LMG 18311) | 38% | 100% |
Q5XEL6 | Streptococcus pyogenes serotype M6 (strain ATCC BAA-946 / MGAS10394) | 39% | 100% |
Q64531 | Mus spretus | 33% | 99% |
Q6DCP3 | Xenopus laevis | 29% | 94% |
Q6GBX8 | Staphylococcus aureus (strain MSSA476) | 36% | 100% |
Q6GJG1 | Staphylococcus aureus (strain MRSA252) | 36% | 100% |
Q6LDD9 | Macaca fascicularis | 33% | 97% |
Q6WIT9 | Canis lupus familiaris | 33% | 97% |
Q7CNQ9 | Streptococcus pyogenes serotype M18 (strain MGAS8232) | 39% | 100% |
Q7KLF3 | Leishmania donovani | 99% | 100% |
Q839B2 | Enterococcus faecalis (strain ATCC 700802 / V583) | 44% | 100% |
Q8CQV4 | Staphylococcus epidermidis (strain ATCC 12228 / FDA PCI 1200) | 36% | 100% |
Q8DRP8 | Streptococcus pneumoniae (strain ATCC BAA-255 / R6) | 39% | 100% |
Q8DWM8 | Streptococcus mutans serotype c (strain ATCC 700610 / UA159) | 36% | 100% |
Q8E2H3 | Streptococcus agalactiae serotype V (strain ATCC BAA-611 / 2603 V/R) | 38% | 100% |
Q8E7Y1 | Streptococcus agalactiae serotype III (strain NEM316) | 38% | 100% |
Q8K9U8 | Buchnera aphidicola subsp. Schizaphis graminum (strain Sg) | 34% | 100% |
Q97TC4 | Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) | 39% | 100% |
Q9NRG1 | Homo sapiens | 35% | 94% |
Q9U6Y2 | Leishmania donovani | 33% | 88% |
Q9W719 | Gallus gallus | 32% | 97% |
V5DEL0 | Trypanosoma cruzi | 36% | 69% |